With regards to transplacental transfer of antimalarial antibodies, Ayisi et al. found that Kenyan HIV+ women (receiving no ART) had reduced transfer of antibodies against only CSP (NANP)5 but not antibodies against MSP1, EBA175, or against peptides of MSP2/MSP3 or tetanus [46]. This evidence concerns the gene ATAD1 and tetanus.